Loading...

Fund Overview

Fund Size

Fund Size

₹1,099 Cr

Expense Ratio

Expense Ratio

2.27%

ISIN

ISIN

INF789F01695

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

28 Jun 1999

About this fund

UTI Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund schemes offered by UTI Mutual Fund. This fund has been in existence for 26 years and 10 days, having been launched on 28-Jun-99.
As of 07-Jul-25, it has a Net Asset Value (NAV) of ₹290.82, Assets Under Management (AUM) of 1098.70 Crores, and an expense ratio of 2.27%.
  • UTI Healthcare Fund Regular Growth has given a CAGR return of 15.05% since inception.
  • The fund's asset allocation comprises around 98.90% in equities, 0.00% in debts, and 1.10% in cash & cash equivalents.
  • You can start investing in UTI Healthcare Fund Regular Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+20.03%

+17.21% (Cat Avg.)

3 Years

+26.82%

+25.95% (Cat Avg.)

5 Years

+22.63%

+22.69% (Cat Avg.)

10 Years

+11.72%

+13.51% (Cat Avg.)

Since Inception

+15.05%

(Cat Avg.)

Portfolio Summaryas of 31st May 2025

Equity1,086.59 Cr98.90%
Others12.11 Cr1.10%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity110.77 Cr10.08%
Cipla LtdEquity60.24 Cr5.48%
Ajanta Pharma LtdEquity54.06 Cr4.92%
Procter & Gamble Health LtdEquity47.21 Cr4.30%
Dr Reddy's Laboratories LtdEquity46.2 Cr4.20%
Glenmark Pharmaceuticals LtdEquity43.85 Cr3.99%
Lupin LtdEquity38.76 Cr3.53%
Apollo Hospitals Enterprise LtdEquity38.38 Cr3.49%
Divi's Laboratories LtdEquity38.13 Cr3.47%
Fortis Healthcare LtdEquity36.94 Cr3.36%
Jupiter Life Line Hospitals LtdEquity33.69 Cr3.07%
Gland Pharma LtdEquity33 Cr3.00%
Cohance Lifesciences LtdEquity30.84 Cr2.81%
Max Healthcare Institute Ltd Ordinary SharesEquity30.62 Cr2.79%
Eris Lifesciences Ltd Registered ShsEquity30.17 Cr2.75%
Caplin Point Laboratories LtdEquity30 Cr2.73%
Krishna Institute of Medical Sciences LtdEquity28.99 Cr2.64%
Aurobindo Pharma LtdEquity28.37 Cr2.58%
Alkem Laboratories LtdEquity23.26 Cr2.12%
Aster DM Healthcare Ltd Ordinary SharesEquity22.99 Cr2.09%
Ipca Laboratories LtdEquity21.35 Cr1.94%
Marksans Pharma LtdEquity19.74 Cr1.80%
Sai Life Sciences LtdEquity19.55 Cr1.78%
Global Health LtdEquity17.59 Cr1.60%
Metropolis Healthcare LtdEquity17.06 Cr1.55%
Sequent Scientific LtdEquity16.79 Cr1.53%
Pfizer LtdEquity16.69 Cr1.52%
Windlas Biotech LtdEquity14.3 Cr1.30%
Vijaya Diagnostic Centre LtdEquity13.79 Cr1.26%
Sanofi Consumer Healthcare India LtdEquity13.55 Cr1.23%
Biocon LtdEquity13.47 Cr1.23%
Torrent Pharmaceuticals LtdEquity12.99 Cr1.18%
Rainbow Childrens Medicare LtdEquity12.88 Cr1.17%
Net Current AssetsCash12 Cr1.09%
Syngene International LtdEquity11.5 Cr1.05%
Alembic Pharmaceuticals LtdEquity11.36 Cr1.03%
Jubilant Pharmova LtdEquity10.86 Cr0.99%
Laxmi Dental LtdEquity10.24 Cr0.93%
Acutaas Chemicals LtdEquity10.21 Cr0.93%
Emcure Pharmaceuticals LtdEquity9.06 Cr0.82%
Orchid Pharma LtdEquity7.14 Cr0.65%
Clearing Corporation Of India Ltd. Std - MarginCash - Repurchase Agreement0.11 Cr0.01%

Allocation By Market Cap (Equity)

Large Cap Stocks

27.30%

Mid Cap Stocks

27.63%

Small Cap Stocks

41.55%

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare1,076.38 Cr97.97%
Basic Materials10.21 Cr0.93%

Risk & Performance Ratios

Standard Deviation

This fund

15.52%

Cat. avg.

15.76%

Lower the better

Sharpe Ratio

This fund

1.21

Cat. avg.

1.14

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

2.10

Higher the better

Fund Managers

KG

Kamal Gada

Since May 2022

Additional Scheme Detailsas of 31st May 2025

ISIN
INF789F01695
Expense Ratio
2.27%
Exit Load
1.00%
Fund Size
₹1,099 Cr
Age
26 years
Lumpsum Minimum
₹5,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Baroda BNP Paribas Health and Wellness Fund Direct Growth

Very High Risk

-1.0%--
Baroda BNP Paribas Health and Wellness Fund Regular Growth

Very High Risk

-1.0%--
Bajaj Finserv Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹321.02 Cr-
Bajaj Finserv Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹321.02 Cr-
PGIM India Healthcare Fund Direct Growth

Very High Risk

0.7%0.0%₹108.88 Cr-
PGIM India Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹108.88 Cr-
WhiteOak Capital Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹331.66 Cr25.3%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹331.66 Cr27.5%
DSP Nifty Healthcare ETF Regular Growth

Very High Risk

0.2%-₹10.25 Cr14.0%
Kotak Healthcare Fund Direct Growth

Very High Risk

0.8%0.0%₹434.55 Cr16.0%
Kotak Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹434.55 Cr14.2%
HDFC Pharma and Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹1704.87 Cr26.5%
HDFC Pharma and Healthcare Fund Direct Growth

Very High Risk

0.8%1.0%₹1704.87 Cr28.0%
Nippon India Pharma Fund Direct Growth

Very High Risk

0.9%1.0%₹8352.16 Cr15.2%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth

Very High Risk

1.9%1.0%₹5507.52 Cr19.6%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Very High Risk

1.1%1.0%₹5507.52 Cr20.6%
DSP Healthcare Fund Direct Growth

Very High Risk

0.6%0.0%₹2961.36 Cr18.2%
DSP Healthcare Fund Regular Growth

Very High Risk

1.9%0.0%₹2961.36 Cr16.6%
LIC MF Healthcare Fund Direct Growth

Very High Risk

1.2%1.0%₹84.19 Cr16.7%
LIC MF Healthcare Fund Regular Growth

Very High Risk

2.5%1.0%₹84.19 Cr15.3%
quant Healthcare Fund Direct Growth

Very High Risk

0.8%1.0%₹417.03 Cr4.8%
quant Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹417.03 Cr3.1%
UTI Healthcare Fund Direct Growth

Very High Risk

1.3%1.0%₹1098.70 Cr21.2%
SBI Healthcare Opportunities Fund Direct Growth

Very High Risk

0.9%0.0%₹3689.28 Cr21.9%
Tata India Pharma & Healthcare Fund Regular Growth

Very High Risk

2.1%0.0%₹1281.99 Cr12.8%
Tata India Pharma & Healthcare Fund Direct Growth

Very High Risk

0.6%0.0%₹1281.99 Cr14.5%
ICICI Prudential Nifty Healthcare ETF

Very High Risk

0.1%-₹144.00 Cr14.1%
SBI Healthcare Opportunities Fund Regular Growth

Very High Risk

1.9%0.0%₹3689.28 Cr20.6%
Nippon India Pharma Fund Regular Growth

Very High Risk

1.8%1.0%₹8352.16 Cr14.2%
UTI Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹1098.70 Cr20.0%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹19.07 Cr13.9%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹967.80 Cr10.0%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

1.9%1.0%₹2690.55 Cr15.3%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2690.55 Cr17.0%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹220.85 Cr13.8%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.5%0.0%₹220.85 Cr16.0%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹37.00 Cr14.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹814.18 Cr11.5%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.1%1.0%₹814.18 Cr13.0%
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹30.06 Cr17.8%

About the AMC

UTI Mutual Fund

UTI Mutual Fund

Total AUM

₹3,29,220 Cr

Address

UTI Towers, Gn Block, Mumbai, 400 051

Other Funds by UTI Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
UTI Multi Cap Fund Direct Growth

Very High Risk

-1.0%₹1042.27 Cr-
UTI Income Plus Arbitrage Active Fund of Fund Direct Growth

Moderately High risk

0.1%0.0%₹123.67 Cr-
UTI Innovation Fund Direct Growth

Very High Risk

0.9%1.0%₹812.37 Cr-0.4%
UTI Fixed Income Interval Fund Annual Plan I Direct Growth

Low Risk

-0.0%₹13.13 Cr6.6%
UTI Fixed Term Income Fund - Series XXXV-I (1260 Days) Direct Growth

Low to Moderate Risk

-0.0%₹316.65 Cr8.2%
UTI Fixed Term Income Fund - Series XXXV-III (1176 Days) Direct Growth

Low to Moderate Risk

-0.0%₹42.79 Cr8.0%
UTI FIIF Ser 2 Qt Interval V Direct Growth

Low Risk

-1.0%₹2.20 Cr6.3%
UTI Fixed Income Interval Fund Quarterly I Direct Growth

Low Risk

-0.0%₹9.74 Cr6.5%
UTI Fixed Inc Intvl Series2 Qt Intvl VI Direct Growth

Moderate Risk

-1.0%₹8.54 Cr6.8%
UTI-Fixed Term Income Fund - Series XXX-VI (1107 days) Direct Growth

Low to Moderate Risk

-0.0%-10.0%
UTI-Fixed Term Income Fund - Series XXX - VII (1294 days) Direct Growth

Low to Moderate Risk

-0.0%--
UTI Fixed Term Income Fund - Series XXXV-II (1223 Days) Direct Growth

Moderate Risk

--₹176.51 Cr8.2%
UTI Fixed Income Interval Fund Annual Plan III Direct Growth

Low to Moderate Risk

-0.0%₹13.38 Cr6.9%
UTI Fixed Term Income Fund - Series XXXVI-I (1574 days) Direct Growth

Low to Moderate Risk

-0.0%₹57.60 Cr9.6%
UTI Floater Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹1410.06 Cr8.4%
UTI Nifty 500 Value 50 Index Fund Direct Growth

Very High Risk

0.6%0.0%₹531.21 Cr-4.5%
UTI Banking & PSU Debt Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹799.59 Cr9.4%
UTI Focused Equity Fund Direct Growth

Very High Risk

0.7%1.0%₹2602.07 Cr2.7%
UTI Silver ETF Fund of Fund Direct Growth

Very High Risk

0.1%1.0%₹62.31 Cr15.3%
UTI Nifty200 Momentum 30 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹8542.91 Cr-13.3%
UTI Overnight Fund Direct Growth

Low Risk

0.1%0.0%₹3571.80 Cr6.4%
UTI Corporate Bond Fund Direct Growth

Moderate Risk

0.3%0.0%₹5572.96 Cr9.9%
UTI Nifty Midcap 150 Quality 50 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹277.05 Cr0.3%
UTI Arbitrage Fund Direct Growth

Low Risk

0.3%0.0%₹7863.14 Cr7.6%
UTI Small Cap Fund Direct Growth

Very High Risk

0.7%1.0%₹4844.38 Cr7.6%
UTI Ultra Short Term Fund Direct Growth

Moderate Risk

0.3%0.0%₹4350.91 Cr8.0%
UTI Credit Risk Fund Direct Growth

Moderately High risk

1.0%1.0%₹282.43 Cr9.8%
UTI Dividend Yield Fund Direct Growth

Very High Risk

1.4%1.0%₹4127.09 Cr4.8%
UTI Banking and Financial Services Fund Direct Growth

Very High Risk

1.1%1.0%₹1355.60 Cr13.3%
UTI Dynamic Bond Fund Direct Growth

Moderate Risk

0.7%0.0%₹472.77 Cr10.1%
UTI Hybrid Equity Fund Direct Growth

Very High Risk

1.2%1.0%₹6254.02 Cr6.8%
UTI Long Term Equity Fund Direct Growth

Very High Risk

0.9%0.0%₹3776.64 Cr3.2%
UTI Flexi Cap Fund Direct Growth

Very High Risk

1.0%1.0%₹26324.59 Cr7.7%
UTI Bond Fund Direct Growth

Moderate Risk

1.2%0.0%₹332.21 Cr9.4%
UTI Liquid Fund Cash Plan Direct Growth

Low to Moderate Risk

0.1%0.0%₹23623.19 Cr7.2%
UTI Gilt Fund Direct Growth

Moderate Risk

0.7%0.0%₹639.15 Cr8.8%
UTI India Consumer Fund Direct Growth

Very High Risk

1.6%1.0%₹710.83 Cr2.0%
UTI Infrastructure Fund Direct Growth

Very High Risk

1.9%1.0%₹2271.83 Cr-2.3%
UTI MNC Fund Direct Growth

Very High Risk

1.2%1.0%₹2867.46 Cr-3.2%
UTI Master Share Unit Scheme Direct Growth

Very High Risk

0.9%1.0%₹12719.69 Cr4.3%
UTI Regular Savings Fund Direct Growth

Moderately High risk

1.2%1.0%₹1683.78 Cr9.0%
UTI Money Market Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹18353.70 Cr8.3%
UTI Mid Cap Fund Direct Growth

Very High Risk

0.9%1.0%₹12224.27 Cr2.1%
UTI Value Opportunities Fund Direct Growth

Very High Risk

1.1%1.0%₹9752.28 Cr6.3%
UTI Healthcare Fund Direct Growth

Very High Risk

1.3%1.0%₹1098.70 Cr21.2%
UTI Nifty 50 Index Fund Direct Growth

Very High Risk

0.2%0.0%₹23249.43 Cr5.7%
UTI Transportation & Logistics Fund Direct Growth

Very High Risk

0.8%1.0%₹3588.60 Cr-2.6%
UTI Short Term Income Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹2822.27 Cr9.6%
UTI - Treasury Advantage Fund Direct Growth

Moderate Risk

0.4%0.0%₹3344.76 Cr8.5%
UTI Multi Asset Fund Direct Growth

High Risk

0.6%1.0%₹5659.43 Cr8.3%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk

Take control of your wealth

Track and Analyse all your investments with Wealth Monitor

qr

Rated ★ 4.3+ on

playstoreappstore

Still got questions?
We're here to help.

The NAV of UTI Healthcare Fund Regular Growth, as of 07-Jul-2025, is ₹290.82.
The fund has generated 20.03% over the last 1 year and 26.82% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 98.90% in equities, 0.00% in bonds, and 1.10% in cash and cash equivalents.
The fund managers responsible for UTI Healthcare Fund Regular Growth are:-
  1. Kamal Gada

Fund Overview

Fund Size

Fund Size

₹1,099 Cr

Expense Ratio

Expense Ratio

2.27%

ISIN

ISIN

INF789F01695

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

28 Jun 1999

Risk Level

Your principal amount will be at Very High Risk

Very High Risk

About this fund

UTI Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund schemes offered by UTI Mutual Fund. This fund has been in existence for 26 years and 10 days, having been launched on 28-Jun-99.
As of 07-Jul-25, it has a Net Asset Value (NAV) of ₹290.82, Assets Under Management (AUM) of 1098.70 Crores, and an expense ratio of 2.27%.
  • UTI Healthcare Fund Regular Growth has given a CAGR return of 15.05% since inception.
  • The fund's asset allocation comprises around 98.90% in equities, 0.00% in debts, and 1.10% in cash & cash equivalents.
  • You can start investing in UTI Healthcare Fund Regular Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+20.03%

+17.21% (Cat Avg.)

3 Years

+26.82%

+25.95% (Cat Avg.)

5 Years

+22.63%

+22.69% (Cat Avg.)

10 Years

+11.72%

+13.51% (Cat Avg.)

Since Inception

+15.05%

(Cat Avg.)

Portfolio Summaryas of 31st May 2025

Equity1,086.59 Cr98.90%
Others12.11 Cr1.10%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity110.77 Cr10.08%
Cipla LtdEquity60.24 Cr5.48%
Ajanta Pharma LtdEquity54.06 Cr4.92%
Procter & Gamble Health LtdEquity47.21 Cr4.30%
Dr Reddy's Laboratories LtdEquity46.2 Cr4.20%
Glenmark Pharmaceuticals LtdEquity43.85 Cr3.99%
Lupin LtdEquity38.76 Cr3.53%
Apollo Hospitals Enterprise LtdEquity38.38 Cr3.49%
Divi's Laboratories LtdEquity38.13 Cr3.47%
Fortis Healthcare LtdEquity36.94 Cr3.36%
Jupiter Life Line Hospitals LtdEquity33.69 Cr3.07%
Gland Pharma LtdEquity33 Cr3.00%
Cohance Lifesciences LtdEquity30.84 Cr2.81%
Max Healthcare Institute Ltd Ordinary SharesEquity30.62 Cr2.79%
Eris Lifesciences Ltd Registered ShsEquity30.17 Cr2.75%
Caplin Point Laboratories LtdEquity30 Cr2.73%
Krishna Institute of Medical Sciences LtdEquity28.99 Cr2.64%
Aurobindo Pharma LtdEquity28.37 Cr2.58%
Alkem Laboratories LtdEquity23.26 Cr2.12%
Aster DM Healthcare Ltd Ordinary SharesEquity22.99 Cr2.09%
Ipca Laboratories LtdEquity21.35 Cr1.94%
Marksans Pharma LtdEquity19.74 Cr1.80%
Sai Life Sciences LtdEquity19.55 Cr1.78%
Global Health LtdEquity17.59 Cr1.60%
Metropolis Healthcare LtdEquity17.06 Cr1.55%
Sequent Scientific LtdEquity16.79 Cr1.53%
Pfizer LtdEquity16.69 Cr1.52%
Windlas Biotech LtdEquity14.3 Cr1.30%
Vijaya Diagnostic Centre LtdEquity13.79 Cr1.26%
Sanofi Consumer Healthcare India LtdEquity13.55 Cr1.23%
Biocon LtdEquity13.47 Cr1.23%
Torrent Pharmaceuticals LtdEquity12.99 Cr1.18%
Rainbow Childrens Medicare LtdEquity12.88 Cr1.17%
Net Current AssetsCash12 Cr1.09%
Syngene International LtdEquity11.5 Cr1.05%
Alembic Pharmaceuticals LtdEquity11.36 Cr1.03%
Jubilant Pharmova LtdEquity10.86 Cr0.99%
Laxmi Dental LtdEquity10.24 Cr0.93%
Acutaas Chemicals LtdEquity10.21 Cr0.93%
Emcure Pharmaceuticals LtdEquity9.06 Cr0.82%
Orchid Pharma LtdEquity7.14 Cr0.65%
Clearing Corporation Of India Ltd. Std - MarginCash - Repurchase Agreement0.11 Cr0.01%

Allocation By Market Cap (Equity)

Large Cap Stocks

27.30%

Mid Cap Stocks

27.63%

Small Cap Stocks

41.55%

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare1,076.38 Cr97.97%
Basic Materials10.21 Cr0.93%

Risk & Performance Ratios

Standard Deviation

This fund

15.52%

Cat. avg.

15.76%

Lower the better

Sharpe Ratio

This fund

1.21

Cat. avg.

1.14

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

2.10

Higher the better

Fund Managers

KG

Kamal Gada

Since May 2022

Additional Scheme Detailsas of 31st May 2025

ISIN
INF789F01695
Expense Ratio
2.27%
Exit Load
1.00%
Fund Size
₹1,099 Cr
Age
26 years
Lumpsum Minimum
₹5,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Baroda BNP Paribas Health and Wellness Fund Direct Growth

Very High Risk

-1.0%--
Baroda BNP Paribas Health and Wellness Fund Regular Growth

Very High Risk

-1.0%--
Bajaj Finserv Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹321.02 Cr-
Bajaj Finserv Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹321.02 Cr-
PGIM India Healthcare Fund Direct Growth

Very High Risk

0.7%0.0%₹108.88 Cr-
PGIM India Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹108.88 Cr-
WhiteOak Capital Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹331.66 Cr25.3%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹331.66 Cr27.5%
DSP Nifty Healthcare ETF Regular Growth

Very High Risk

0.2%-₹10.25 Cr14.0%
Kotak Healthcare Fund Direct Growth

Very High Risk

0.8%0.0%₹434.55 Cr16.0%
Kotak Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹434.55 Cr14.2%
HDFC Pharma and Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹1704.87 Cr26.5%
HDFC Pharma and Healthcare Fund Direct Growth

Very High Risk

0.8%1.0%₹1704.87 Cr28.0%
Nippon India Pharma Fund Direct Growth

Very High Risk

0.9%1.0%₹8352.16 Cr15.2%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth

Very High Risk

1.9%1.0%₹5507.52 Cr19.6%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Very High Risk

1.1%1.0%₹5507.52 Cr20.6%
DSP Healthcare Fund Direct Growth

Very High Risk

0.6%0.0%₹2961.36 Cr18.2%
DSP Healthcare Fund Regular Growth

Very High Risk

1.9%0.0%₹2961.36 Cr16.6%
LIC MF Healthcare Fund Direct Growth

Very High Risk

1.2%1.0%₹84.19 Cr16.7%
LIC MF Healthcare Fund Regular Growth

Very High Risk

2.5%1.0%₹84.19 Cr15.3%
quant Healthcare Fund Direct Growth

Very High Risk

0.8%1.0%₹417.03 Cr4.8%
quant Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹417.03 Cr3.1%
UTI Healthcare Fund Direct Growth

Very High Risk

1.3%1.0%₹1098.70 Cr21.2%
SBI Healthcare Opportunities Fund Direct Growth

Very High Risk

0.9%0.0%₹3689.28 Cr21.9%
Tata India Pharma & Healthcare Fund Regular Growth

Very High Risk

2.1%0.0%₹1281.99 Cr12.8%
Tata India Pharma & Healthcare Fund Direct Growth

Very High Risk

0.6%0.0%₹1281.99 Cr14.5%
ICICI Prudential Nifty Healthcare ETF

Very High Risk

0.1%-₹144.00 Cr14.1%
SBI Healthcare Opportunities Fund Regular Growth

Very High Risk

1.9%0.0%₹3689.28 Cr20.6%
Nippon India Pharma Fund Regular Growth

Very High Risk

1.8%1.0%₹8352.16 Cr14.2%
UTI Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹1098.70 Cr20.0%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹19.07 Cr13.9%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹967.80 Cr10.0%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

1.9%1.0%₹2690.55 Cr15.3%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2690.55 Cr17.0%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹220.85 Cr13.8%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.5%0.0%₹220.85 Cr16.0%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹37.00 Cr14.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹814.18 Cr11.5%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.1%1.0%₹814.18 Cr13.0%
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹30.06 Cr17.8%

About the AMC

UTI Mutual Fund

UTI Mutual Fund

Total AUM

₹3,29,220 Cr

Address

UTI Towers, Gn Block, Mumbai, 400 051

Other Funds by UTI Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
UTI Multi Cap Fund Direct Growth

Very High Risk

-1.0%₹1042.27 Cr-
UTI Income Plus Arbitrage Active Fund of Fund Direct Growth

Moderately High risk

0.1%0.0%₹123.67 Cr-
UTI Innovation Fund Direct Growth

Very High Risk

0.9%1.0%₹812.37 Cr-0.4%
UTI Fixed Income Interval Fund Annual Plan I Direct Growth

Low Risk

-0.0%₹13.13 Cr6.6%
UTI Fixed Term Income Fund - Series XXXV-I (1260 Days) Direct Growth

Low to Moderate Risk

-0.0%₹316.65 Cr8.2%
UTI Fixed Term Income Fund - Series XXXV-III (1176 Days) Direct Growth

Low to Moderate Risk

-0.0%₹42.79 Cr8.0%
UTI FIIF Ser 2 Qt Interval V Direct Growth

Low Risk

-1.0%₹2.20 Cr6.3%
UTI Fixed Income Interval Fund Quarterly I Direct Growth

Low Risk

-0.0%₹9.74 Cr6.5%
UTI Fixed Inc Intvl Series2 Qt Intvl VI Direct Growth

Moderate Risk

-1.0%₹8.54 Cr6.8%
UTI-Fixed Term Income Fund - Series XXX-VI (1107 days) Direct Growth

Low to Moderate Risk

-0.0%-10.0%
UTI-Fixed Term Income Fund - Series XXX - VII (1294 days) Direct Growth

Low to Moderate Risk

-0.0%--
UTI Fixed Term Income Fund - Series XXXV-II (1223 Days) Direct Growth

Moderate Risk

--₹176.51 Cr8.2%
UTI Fixed Income Interval Fund Annual Plan III Direct Growth

Low to Moderate Risk

-0.0%₹13.38 Cr6.9%
UTI Fixed Term Income Fund - Series XXXVI-I (1574 days) Direct Growth

Low to Moderate Risk

-0.0%₹57.60 Cr9.6%
UTI Floater Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹1410.06 Cr8.4%
UTI Nifty 500 Value 50 Index Fund Direct Growth

Very High Risk

0.6%0.0%₹531.21 Cr-4.5%
UTI Banking & PSU Debt Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹799.59 Cr9.4%
UTI Focused Equity Fund Direct Growth

Very High Risk

0.7%1.0%₹2602.07 Cr2.7%
UTI Silver ETF Fund of Fund Direct Growth

Very High Risk

0.1%1.0%₹62.31 Cr15.3%
UTI Nifty200 Momentum 30 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹8542.91 Cr-13.3%
UTI Overnight Fund Direct Growth

Low Risk

0.1%0.0%₹3571.80 Cr6.4%
UTI Corporate Bond Fund Direct Growth

Moderate Risk

0.3%0.0%₹5572.96 Cr9.9%
UTI Nifty Midcap 150 Quality 50 Index Fund Direct Growth

Very High Risk

0.4%0.0%₹277.05 Cr0.3%
UTI Arbitrage Fund Direct Growth

Low Risk

0.3%0.0%₹7863.14 Cr7.6%
UTI Small Cap Fund Direct Growth

Very High Risk

0.7%1.0%₹4844.38 Cr7.6%
UTI Ultra Short Term Fund Direct Growth

Moderate Risk

0.3%0.0%₹4350.91 Cr8.0%
UTI Credit Risk Fund Direct Growth

Moderately High risk

1.0%1.0%₹282.43 Cr9.8%
UTI Dividend Yield Fund Direct Growth

Very High Risk

1.4%1.0%₹4127.09 Cr4.8%
UTI Banking and Financial Services Fund Direct Growth

Very High Risk

1.1%1.0%₹1355.60 Cr13.3%
UTI Dynamic Bond Fund Direct Growth

Moderate Risk

0.7%0.0%₹472.77 Cr10.1%
UTI Hybrid Equity Fund Direct Growth

Very High Risk

1.2%1.0%₹6254.02 Cr6.8%
UTI Long Term Equity Fund Direct Growth

Very High Risk

0.9%0.0%₹3776.64 Cr3.2%
UTI Flexi Cap Fund Direct Growth

Very High Risk

1.0%1.0%₹26324.59 Cr7.7%
UTI Bond Fund Direct Growth

Moderate Risk

1.2%0.0%₹332.21 Cr9.4%
UTI Liquid Fund Cash Plan Direct Growth

Low to Moderate Risk

0.1%0.0%₹23623.19 Cr7.2%
UTI Gilt Fund Direct Growth

Moderate Risk

0.7%0.0%₹639.15 Cr8.8%
UTI India Consumer Fund Direct Growth

Very High Risk

1.6%1.0%₹710.83 Cr2.0%
UTI Infrastructure Fund Direct Growth

Very High Risk

1.9%1.0%₹2271.83 Cr-2.3%
UTI MNC Fund Direct Growth

Very High Risk

1.2%1.0%₹2867.46 Cr-3.2%
UTI Master Share Unit Scheme Direct Growth

Very High Risk

0.9%1.0%₹12719.69 Cr4.3%
UTI Regular Savings Fund Direct Growth

Moderately High risk

1.2%1.0%₹1683.78 Cr9.0%
UTI Money Market Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹18353.70 Cr8.3%
UTI Mid Cap Fund Direct Growth

Very High Risk

0.9%1.0%₹12224.27 Cr2.1%
UTI Value Opportunities Fund Direct Growth

Very High Risk

1.1%1.0%₹9752.28 Cr6.3%
UTI Healthcare Fund Direct Growth

Very High Risk

1.3%1.0%₹1098.70 Cr21.2%
UTI Nifty 50 Index Fund Direct Growth

Very High Risk

0.2%0.0%₹23249.43 Cr5.7%
UTI Transportation & Logistics Fund Direct Growth

Very High Risk

0.8%1.0%₹3588.60 Cr-2.6%
UTI Short Term Income Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹2822.27 Cr9.6%
UTI - Treasury Advantage Fund Direct Growth

Moderate Risk

0.4%0.0%₹3344.76 Cr8.5%
UTI Multi Asset Fund Direct Growth

High Risk

0.6%1.0%₹5659.43 Cr8.3%

Still got questions?
We're here to help.

The NAV of UTI Healthcare Fund Regular Growth, as of 07-Jul-2025, is ₹290.82.
The fund has generated 20.03% over the last 1 year and 26.82% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 98.90% in equities, 0.00% in bonds, and 1.10% in cash and cash equivalents.
The fund managers responsible for UTI Healthcare Fund Regular Growth are:-
  1. Kamal Gada
close

Get your portfolio reviewed by experts

qr

Track all your investments in one place

Download Wealth Monitor App

cross
wm logo

Track and monitor all
your investments